FDA-Drug2019-12-11Class II
EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,
Pacira Pharmaceuticals, Inc.
Hazard
Sub Potent Drug: Out of Specification (OOS)
Sold states
Distributed Nationwide in the USA
Affected count
910 20 mL vials
Manufactured in
10450 Science Center Dr, San Diego, CA, United States
Products
EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0621-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief